UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Impact of the Early Benefit Assessment on A Pharmaceutical's Real Consumption in Germany

Value in health, 2014-11, Vol.17 (7), p.A416-A416

2014

Link zum Volltext

Verfügbarkeit prüfen

PHP35 - AMNOG EARLY BENEFIT ASSESSMENT (EBA) AND MARKET PENETRATION OF NEW DRUGS FOR MELANOMA, MULTIPLE SCLEROSIS AND DIABETES MELLITUS IN GERMANY

Value in health, 2018-10, Vol.21, p.S156-S156

2018

Link zum Volltext

Verfügbarkeit prüfen

PCN291 - Regional Differences In Potential Savings For The Medical Treatment Of Advanced Prostate Cancer In The German Health Care System

Value in health, 2017-10, Vol.20 (9), p.A464-A464

2017

Link zum Volltext

Verfügbarkeit prüfen

Regional Differences In Potential Savings For The Medical Treatment Of Advanced Prostate Cancer In The German Health Care System

Value in health, 2017-10, Vol.20 (9), p.A464

2017

Link zum Volltext

Verfügbarkeit prüfen

PND73 Multiple Sclerosis in Germany: Outpatient Health Care Patterns

Value in health, 2012-11, Vol.15 (7), p.A559-A559

2012

Link zum Volltext

Verfügbarkeit prüfen

Healthcare utilization of back pain patients: results of a claims data analysis

Journal of medical economics, 2011, Vol.14 (6), p.816-823

2011

Link zum Volltext

Verfügbarkeit prüfen

PNS144 HOW THE RESULTS OF THE AMNOG EARLY BENEFIT ASSESSMENT (EBA) IN GERMANY HAVE DEVELOPED OVER TIME

Value in health, 2019-11, Vol.22, p.S785-S785

2019

Link zum Volltext

Verfügbarkeit prüfen

ANALYSIS OF HORMONE THERAPY PRESCRIPTION RATES BEFORE AND AFTER THE WHI STUDY USING CLAIMS DATA OF A GERMAN SICKNESS FUND

Maturitas, 2009, Vol.63, p.S74-S74

2009

Link zum Volltext

Verfügbarkeit prüfen

PHP53 - Is The Proof of an Additional Benefit under amnog in Germany More Difficult for Certain Drugs than for Other Ones?

Value in health, 2015-11, Vol.18 (7), p.A523-A523

2015

Link zum Volltext

Verfügbarkeit prüfen

Is The Proof of an Additional Benefit under amnog in Germany More Difficult for Certain Drugs than for Other Ones?

Value in health, 2015-11, Vol.18 (7), p.A523-A523

2015

Link zum Volltext

Verfügbarkeit prüfen

PRS28 - Effect of CVD on COPD Related Resource Utilization and Direct Medical Costs Among Statutory Heatlh Insured Patients In Germany

Value in health, 2016-11, Vol.19 (7), p.A553-A553

2016

Link zum Volltext

Verfügbarkeit prüfen

Effect of CVD on COPD Related Resource Utilization and Direct Medical Costs Among Statutory Heatlh Insured Patients In Germany

Value in health, 2016-11, Vol.19 (7), p.A553-A553

2016

Link zum Volltext

Verfügbarkeit prüfen

PHP71 - Impact of the Early Benefit Assessment on A Pharmaceutical's Real Consumption in Germany

Value in health, 2014-11, Vol.17 (7), p.A416-A416

2014

Link zum Volltext

Verfügbarkeit prüfen

Persistence and adherence with antihypertensive drug therapy in a German sickness fund population

Journal of human hypertension, 2007-09, Vol.21 (9), p.744-746

2007

Link zum Volltext

Verfügbarkeit prüfen

PHP30 COST DRIVERS IN THE PHARMACEUTICAL MARKET IN GERMANY IN 2007

Value in health, 2008, Vol.11 (6), p.A371-A371

2008

Link zum Volltext

Verfügbarkeit prüfen

Histamine increases cytosolic Ca2+ in HL-60 promyelocytes predominantly via H2 receptors with an unique agonist/antagonist profile and induces functional differentiation

Molecular pharmacology, 1992-08, Vol.42 (2), p.235-241

1992

Link zum Volltext

Verfügbarkeit prüfen

Signaling effects of α-thrombin and SFLLRN in rat glioma C6 cells

Journal of neuroscience research, 1996-12, Vol.46 (6), p.641-651

1996

Link zum Volltext

Verfügbarkeit prüfen

Identification and grouping of pain patients according to claims data

Schmerz (Berlin, Germany), 2010-02, Vol.24 (1), p.12

2010

Link zum Volltext

Verfügbarkeit prüfen

Persistency with oral bisphosphonates in cancer patients

Journal of clinical oncology, 2005-06, Vol.23 (16_suppl), p.8221-8221

2005

Link zum Volltext

Verfügbarkeit prüfen

Histamine increases cytosolic Ca2+ in dibutyryl-cAMP-differentiated HL-60 cells via H1 receptors and is an incomplete secretagogue

Molecular pharmacology, 1992-08, Vol.42 (2), p.227-234

1992

Link zum Volltext

Verfügbarkeit prüfen

PIH12 HORMONE REPLACEMENT THERAPY OF MENOPAUSAL WOMEN—ANALYSIS OF PRESCRIPTION PATTERN CHANGES BEFORE AND AFTER THE WHI STUDY USING CLAIMS DATA OF A GERMAN SICKNESS FUND

Value in health, 2007, Vol.10 (6), p.A376-A376

2007

Link zum Volltext

Verfügbarkeit prüfen

PRS1 PREVALENCE AND TREATMENT OF COPD IN GERMANY

Value in health, 2006-11, Vol.9 (6), p.A260-A260

2006

Link zum Volltext

Verfügbarkeit prüfen

PMH54 INDICATION SPECTRUM OF SNRI APPLIED FOR THE TREATMENT OF DEPRESSION—A PHARMACOEPIDEMIOLOGICAL ANALYSIS OF CLAIMS DATA OF A GERMAN SICKNESS FUND

Value in health, 2008, Vol.11 (6), p.A597-A597

2008

Link zum Volltext

Verfügbarkeit prüfen

Transdermal and oral opioids for outpatient pain therapy. Comparing patients' characteristics by a claims data analysis

Schmerz (Berlin, Germany), 2008-04, Vol.22 (2), p.156

2008

Link zum Volltext

Verfügbarkeit prüfen

Opioid therapy in patients with back pain. Claims data analysis for patient group characterization, influence on opioid therapy and work disability

Schmerz (Berlin, Germany), 2011-04, Vol.25 (2), p.174-183

2011

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 298

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(212)
Mit Volltextzugriff
(239)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(110)
Life Sciences & Biomedicine
(90)
Humans
(88)
Male
(49)
Biological And Medical Sciences
(41)
Female
(40)
Animals
(38)
Middle Aged
(31)
Adult
(29)
Medical Sciences
(29)
Aged
(22)
Surgery
(21)
Calibration
(20)
Biochemistry & Molecular Biology
(17)
Engineering
(16)
Technology
(15)
Nist
(14)
Engineering, Electrical & Electronic
(13)
Fundamental And Applied Biological Sciences. Psychology
(13)
Reflection
(13)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Impact of the Early Benefit Assessment on A Pharmaceutical's Real Consumption in Germany

PHP35 - AMNOG EARLY BENEFIT ASSESSMENT (EBA) AND MARKET PENETRATION OF NEW DRUGS FOR MELANOMA, MULTIPLE SCLEROSIS AND DIABETES MELLITUS IN GERMANY

PCN291 - Regional Differences In Potential Savings For The Medical Treatment Of Advanced Prostate Cancer In The German Health Care System

Regional Differences In Potential Savings For The Medical Treatment Of Advanced Prostate Cancer In The German Health Care System

PND73 Multiple Sclerosis in Germany: Outpatient Health Care Patterns

Healthcare utilization of back pain patients: results of a claims data analysis

PNS144 HOW THE RESULTS OF THE AMNOG EARLY BENEFIT ASSESSMENT (EBA) IN GERMANY HAVE DEVELOPED OVER TIME

ANALYSIS OF HORMONE THERAPY PRESCRIPTION RATES BEFORE AND AFTER THE WHI STUDY USING CLAIMS DATA OF A GERMAN SICKNESS FUND

PHP53 - Is The Proof of an Additional Benefit under amnog in Germany More Difficult for Certain Drugs than for Other Ones?

Is The Proof of an Additional Benefit under amnog in Germany More Difficult for Certain Drugs than for Other Ones?

PRS28 - Effect of CVD on COPD Related Resource Utilization and Direct Medical Costs Among Statutory Heatlh Insured Patients In Germany

Effect of CVD on COPD Related Resource Utilization and Direct Medical Costs Among Statutory Heatlh Insured Patients In Germany

PHP71 - Impact of the Early Benefit Assessment on A Pharmaceutical's Real Consumption in Germany

Persistence and adherence with antihypertensive drug therapy in a German sickness fund population

PHP30 COST DRIVERS IN THE PHARMACEUTICAL MARKET IN GERMANY IN 2007

Histamine increases cytosolic Ca2+ in HL-60 promyelocytes predominantly via H2 receptors with an unique agonist/antagonist profile and induces functional differentiation

Signaling effects of α-thrombin and SFLLRN in rat glioma C6 cells

Identification and grouping of pain patients according to claims data

Persistency with oral bisphosphonates in cancer patients

Histamine increases cytosolic Ca2+ in dibutyryl-cAMP-differentiated HL-60 cells via H1 receptors and is an incomplete secretagogue

PIH12 HORMONE REPLACEMENT THERAPY OF MENOPAUSAL WOMEN—ANALYSIS OF PRESCRIPTION PATTERN CHANGES BEFORE AND AFTER THE WHI STUDY USING CLAIMS DATA OF A GERMAN SICKNESS FUND

PRS1 PREVALENCE AND TREATMENT OF COPD IN GERMANY

PMH54 INDICATION SPECTRUM OF SNRI APPLIED FOR THE TREATMENT OF DEPRESSION—A PHARMACOEPIDEMIOLOGICAL ANALYSIS OF CLAIMS DATA OF A GERMAN SICKNESS FUND

Transdermal and oral opioids for outpatient pain therapy. Comparing patients' characteristics by a claims data analysis

Opioid therapy in patients with back pain. Claims data analysis for patient group characterization, influence on opioid therapy and work disability

Suchergebnisse filtern